Celebrex and Neutrophil count abnormal - a phase IV clinical study of FDA data

Summary:

Neutrophil count abnormal is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Thalidomide, and have Medulloblastoma.

The phase IV clinical study analyzes which people have Neutrophil count abnormal when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.

What is Neutrophil count abnormal?

Neutrophil count abnormal (abnormal number of neutrophil a type of blood cell) is found to be associated with 312 drugs and 402 conditions by eHealthMe. Check the latest studies of Neutrophil count abnormal.

On Jul, 15, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 23 people (0.02%) have Neutrophil count abnormal.

Could Celebrex cause Neutrophil count abnormal?

Among these 23 people:

How long have people been on Celebrex when they have Neutrophil count abnormal? *

What is the gender of people who have Neutrophil count abnormal when taking Celebrex? *

female: 43.48 %
male: 56.52 %

What is the age of people who have Neutrophil count abnormal when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Neutrophil count abnormal? *

White Blood Cell Count Abnormal: 5 people, 21.74%
White Blood Cell Count Increased: 4 people, 17.39%
Dehydration (dryness resulting from the removal of water): 4 people, 17.39%
White Blood Cell Count Decreased: 4 people, 17.39%
Haematocrit: 4 people, 17.39%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 17.39%
Nausea (feeling of having an urge to vomit): 4 people, 17.39%
Bacterial Infection: 4 people, 17.39%
Fainting (loss of consciousness and postural tone): 4 people, 17.39%
Diarrhea: 4 people, 17.39%

What are the existing conditions these people have? *

Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 2 people, 8.70%
Prostate Cancer: 2 people, 8.70%
Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 2 people, 8.70%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 4.35%
Bipolar Disorder (mood disorder): 1 person, 4.35%
Cervix Carcinoma (cancer of cervix): 1 person, 4.35%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.35%
Dry Eyes (lack of adequate tears): 1 person, 4.35%
Ependymoma (tumour in the brain): 1 person, 4.35%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Neutrophil count abnormal?

- Check whether Neutrophil count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,105 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neutrophil count abnormal:

Neutrophil count abnormal (312 drugs)

Browse all the conditions that are associated with Neutrophil count abnormal:

Neutrophil count abnormal (402 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.